Literature DB >> 17940305

Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability.

Hedvig Hricak1, Constantine Gatsonis, Fergus V Coakley, Bradley Snyder, Caroline Reinhold, Lawrence H Schwartz, Paula J Woodward, Harpreet K Pannu, Marco Amendola, Donald G Mitchell.   

Abstract

PURPOSE: To retrospectively compare diagnostic performance and interobserver variability for computed tomography (CT) and magnetic resonance (MR) imaging in the pretreatment evaluation of early invasive cervical cancer, with surgical pathologic findings as the reference standard.
MATERIALS AND METHODS: This HIPAA-compliant study had institutional review board approval and informed consent for evaluation of preoperative CT (n = 146) and/or MR imaging (n = 152) studies in 156 women (median age, 43 years; range, 22-81 years) from a previous prospective multicenter American College of Radiology Imaging Network and Gynecologic Oncology Group study of 172 women with biopsy-proved cervical cancer (clinical stage > or = IB). Four radiologists (experience, 7-15 years) interpreted the CT scans, and four radiologists (experience, 12-20 years) interpreted the MR studies retrospectively. Tumor visualization and detection of parametrial invasion were assessed with receiver operating characteristic curves (with P < or = .05 considered to indicate a significant difference). Descriptive statistics for staging and kappa statistics for reader agreement were calculated. Surgical pathologic findings were the reference standard.
RESULTS: For CT and MR imaging, respectively, multirater kappa values were 0.26 and 0.44 for staging, 0.16 and 0.32 for tumor visualization, and -0.04 and 0.11 for detection of parametrial invasion; for advanced stage cancer (> or =IIB), sensitivities were 0.14-0.38 and 0.40-0.57, positive predictive values (PPVs) were 0.38-1.00 and 0.32-0.39, specificities were 0.84-1.00 and 0.77-0.80, and negative predictive values (NPVs) were 0.81-0.84 and 0.83-0.87. MR imaging was significantly better than CT for tumor visualization (P < .001) and detection of parametrial invasion (P = .047).
CONCLUSION: Reader agreement was higher for MR imaging than for CT but was low for both. MR imaging was significantly better than CT for tumor visualization and detection of parametrial invasion. The modalities were similar for staging, sharing low sensitivity and PPV but relatively high NPV and specificity.

Entities:  

Mesh:

Year:  2007        PMID: 17940305     DOI: 10.1148/radiol.2452061983

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  41 in total

1.  In reply.

Authors:  Yoo-Kyung Lee; Seung-Su Han; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

Review 2.  MRI in medical practice and its future use in radiation oncology. Resume of XXV GOCO Congress (Montpellier) 2017.

Authors:  Xavier Druet; Estrella Acosta Sanchez; Ken Soleakhena; Anne Laprie; Jordi Sáez; Stéphanie Nougaret; Olivier Riou; Elodie Rigal; Laura Kibranian; Miguel Palacios; Ismael Membrive
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-05

Review 3.  Fertility-sparing for young patients with gynecologic cancer: How MRI can guide patient selection prior to conservative management.

Authors:  Sinead H McEvoy; Stephanie Nougaret; Nadeem R Abu-Rustum; Hebert Alberto Vargas; Elizabeth A Sadowski; Christine O Menias; Fuki Shitano; Shinya Fujii; Ramon E Sosa; Joanna G Escalon; Evis Sala; Yulia Lakhman
Journal:  Abdom Radiol (NY)       Date:  2017-10

4.  Surgical management of early cervical cancer: the shape of future studies.

Authors:  Stefano Greggi; Cono Scaffa
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

Review 5.  Early Cervical Cancer: Current Dilemmas of Staging and Surgery.

Authors:  Tiffany Zigras; Genevieve Lennox; Karla Willows; Allan Covens
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

Review 6.  Current imaging strategies for the evaluation of uterine cervical cancer.

Authors:  Charis Bourgioti; Konstantinos Chatoupis; Lia Angela Moulopoulos
Journal:  World J Radiol       Date:  2016-04-28

7.  Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.

Authors:  Kazuya Nakajo; Mitsuaki Tatsumi; Atsuo Inoue; Kayako Isohashi; Ichiro Higuchi; Hiroki Kato; Masao Imaizumi; Takayuki Enomoto; Eku Shimosegawa; Tadashi Kimura; Jun Hatazawa
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

8.  3-T MR-guided brachytherapy for gynecologic malignancies.

Authors:  Tina Kapur; Jan Egger; Antonio Damato; Ehud J Schmidt; Akila N Viswanathan
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

9.  Inter- and intra-rater reliability of blood and cerebrospinal fluid flow quantification by phase-contrast MRI.

Authors:  Inga Koerte; Caroline Haberl; Michael Schmidt; Andreas Pomschar; Sang Lee; Petra Rapp; Denise Steffinger; Rong-Wen Tain; Noam Alperin; Birgit Ertl-Wagner
Journal:  J Magn Reson Imaging       Date:  2013-01-31       Impact factor: 4.813

10.  Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer.

Authors:  Gaiane M Rauch; Harmeet Kaur; Haesun Choi; Randy D Ernst; Ann H Klopp; Piyaporn Boonsirikamchai; Shannon N Westin; Leonardo P Marcal
Journal:  Radiographics       Date:  2014 Jul-Aug       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.